We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Functional Electrical Stimulation for Footdrop in Hemiparesis
Updated: 12/31/1969
Functional Electrical Stimulation for Footdrop in Hemiparesis
Status: Enrolling
Updated: 12/31/1969
Functional Electrical Stimulation for Footdrop in Hemiparesis
Updated: 12/31/1969
Functional Electrical Stimulation for Footdrop in Hemiparesis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
Updated: 12/31/1969
Neuroimaging Correlates of Monocyte/Macrophage Infiltration in HIV-infected Individuals: A Cross-sectional Pilot Study Using IV Ferumoxytol
Status: Enrolling
Updated: 12/31/1969
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
Updated: 12/31/1969
Neuroimaging Correlates of Monocyte/Macrophage Infiltration in HIV-infected Individuals: A Cross-sectional Pilot Study Using IV Ferumoxytol
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Parents Workgroup About Emotion Regulation
Updated: 12/31/1969
Parenting Workshop on Emotion Regulation
Status: Enrolling
Updated: 12/31/1969
Parents Workgroup About Emotion Regulation
Updated: 12/31/1969
Parenting Workshop on Emotion Regulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
Updated: 12/31/1969
An Open-Label Study to Evaluate the Long-Term Safety of Arbaclofen Extended-Release Tablets in Multiple Sclerosis Patients With Spasticity (Study OS440-3005)
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
Updated: 12/31/1969
An Open-Label Study to Evaluate the Long-Term Safety of Arbaclofen Extended-Release Tablets in Multiple Sclerosis Patients With Spasticity (Study OS440-3005)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Vestibular Stimulation to Treat Hemispatial Neglect
Updated: 12/31/1969
Noise Enhanced Galvanic Vestibular Stimulation in Hemispatial Neglect
Status: Enrolling
Updated: 12/31/1969
Vestibular Stimulation to Treat Hemispatial Neglect
Updated: 12/31/1969
Noise Enhanced Galvanic Vestibular Stimulation in Hemispatial Neglect
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
The SUCCEED Trial of Secondary Stroke Prevention
Updated: 12/31/1969
Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Updated: 12/31/1969
A Single Center Dose Ranging Pilot Study of (+)-Epicatechin in Non-ambulatory Adolescents With Duchenne Muscular Dystrophy and Pre-symptomatic Cardiac Dysfunction
Status: Enrolling
Updated: 12/31/1969
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Updated: 12/31/1969
A Single Center Dose Ranging Pilot Study of (+)-Epicatechin in Non-ambulatory Adolescents With Duchenne Muscular Dystrophy and Pre-symptomatic Cardiac Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
(-)- Epicatechin Becker Muscular Dystrophy
Updated: 12/31/1969
UCD0115B: An Open-label Extension Study of Purified Epicatechin to Improve Mitochondrial Function, Strength and Skeletal Muscle Exercise Response in Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
(-)- Epicatechin Becker Muscular Dystrophy
Updated: 12/31/1969
UCD0115B: An Open-label Extension Study of Purified Epicatechin to Improve Mitochondrial Function, Strength and Skeletal Muscle Exercise Response in Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ketamine Versus Midazolam for Prehospital Agitation
Updated: 12/31/1969
Ketamine Versus Midazolam for Prehospital Agitation
Status: Enrolling
Updated: 12/31/1969
Ketamine Versus Midazolam for Prehospital Agitation
Updated: 12/31/1969
Ketamine Versus Midazolam for Prehospital Agitation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Resilience-Based Program for Support Partners of Persons With Multiple Sclerosis
Updated: 12/31/1969
A Pilot Single-Center Study of a Manualized Resilience-Based Telehealth Program for Support Partners of Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Resilience-Based Program for Support Partners of Persons With Multiple Sclerosis
Updated: 12/31/1969
A Pilot Single-Center Study of a Manualized Resilience-Based Telehealth Program for Support Partners of Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD
Updated: 12/31/1969
The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD
Status: Enrolling
Updated: 12/31/1969
Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD
Updated: 12/31/1969
The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of Coenzyme Q10 in PSP and CBD
Updated: 12/31/1969
Effects of Coenzyme Q10 in PSP and CBD, A Randomized, Placebo-Controlled, Double Blind Cross Over Pilot Study
Status: Enrolling
Updated: 12/31/1969
Effects of Coenzyme Q10 in PSP and CBD
Updated: 12/31/1969
Effects of Coenzyme Q10 in PSP and CBD, A Randomized, Placebo-Controlled, Double Blind Cross Over Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sensory Stimulation During CIMT
Updated: 12/31/1969
Sensory Stimulation During Constraint-Induced Movement Therapy
Status: Enrolling
Updated: 12/31/1969
Sensory Stimulation During CIMT
Updated: 12/31/1969
Sensory Stimulation During Constraint-Induced Movement Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Epidemiology of Sleep-Disordered Breathing in Adults
Updated: 12/31/1969
Epidemiology of Sleep-Disordered Breathing in Adults
Status: Enrolling
Updated: 12/31/1969
Epidemiology of Sleep-Disordered Breathing in Adults
Updated: 12/31/1969
Epidemiology of Sleep-Disordered Breathing in Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
Updated: 12/31/1969
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
Status: Enrolling
Updated: 12/31/1969
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
Updated: 12/31/1969
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years
Updated: 12/31/1969
Retrospective Review of Indications and Results of Brain MRI With Anesthesia/Sedation in Children Less Than Three Years of Age
Status: Enrolling
Updated: 12/31/1969
Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years
Updated: 12/31/1969
Retrospective Review of Indications and Results of Brain MRI With Anesthesia/Sedation in Children Less Than Three Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
Updated: 12/31/1969
The Effects of a Sensorimotor Rehabilitation Program on the Upper and Lower Limbs of Persons With Cancer Following Taxane-Based Chemotherapy for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
Updated: 12/31/1969
The Effects of a Sensorimotor Rehabilitation Program on the Upper and Lower Limbs of Persons With Cancer Following Taxane-Based Chemotherapy for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Cognition in Multiple Sclerosis
Updated: 12/31/1969
Effect of a Digital Therapeutic on Processing Speed in Adults With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Digital Cognition in Multiple Sclerosis
Updated: 12/31/1969
Effect of a Digital Therapeutic on Processing Speed in Adults With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)
Updated: 12/31/1969
EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)
Status: Enrolling
Updated: 12/31/1969
EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)
Updated: 12/31/1969
EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Updated: 12/31/1969
A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials